Antioxidants in the Treatment of Chronic Diffuse Liver Diseases (the Results of the “MAXAR” Observational Program) by M. V. Mayevskaya, V. T. Ivashkin, V. D. Lunkov, S. P. Kryzhanovskiy, I. Yu. Pirogova, Ch. S. Pavlov, M. S. Zharkova, A. G. Beniashvili, M. A. Morozova

Subjects: Get full text

A positive relationship between weight-adjusted waist index and non-alcoholic fatty liver disease: a study on US adolescents by Xiaoling Cui, Xiaoling Cui, Yize Huang, Luyang Kang, Lianxiu Han, Weijie Sun, Kexing Han, Yufeng Gao

Subjects: Get full text

Two-Dimensional Shear-Wave Elastography: Accuracy in Liver Fibrosis Staging Using Magnetic Resonance Elastography as the Reference Standard by Puwitch Charoenchue, Jiraporn Khorana, Taned Chitapanarux, Nakarin Inmutto, Wittanee Na Chiangmai, Amonlaya Amantakul, Suwalee Pojchamarnwiputh, Apichat Tantraworasin

Subjects: Get full text

Liver macrophage activation: Relation with hepatic histopathological changes in patients with metabolic associated steatotic liver disease by Doaa H. Hegazy, Fathalla S. Mohamed, Sabah A. H. Mahmoud, Nevine M. F. El Deeb, Amany Elyamany, Ahmed M. Elgendi

Subjects: “…metabolic associated steatotic liver disease…”
Get full text

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease by Anna E. Płatek, Julia A. Szymańska

Subjects: Get full text

Practical Aspects of Clinical Manifestations, Pathogenesis and Therapy of Alcoholic Liver Disease and Non-alcoholic Fatty Liver Disease: Expert Opinion by V. V. Tsukanov, M. F. Osipenko, E. V. Beloborodova, M. A. Livzan, I. B. Khlynov, S. A. Alekseenko, Yu. P. Sivolap, J. L. Tonkikh, A. V. Vasyutin

Subjects: “…alcoholic liver disease (ald)…”
Get full text

MDTR: a knowledge-guided interpretable representation for quantifying liver toxicity at transcriptomic level by Inyoung Sung, Sangseon Lee, Dongmin Bang, Dongmin Bang, Jungseob Yi, Sunho Lee, Sun Kim, Sun Kim, Sun Kim, Sun Kim

Subjects: “…drug-induced liver injury…”
Get full text

Correlation between liver fibrosis in non-alcoholic fatty liver disease and insulin resistance indicators: a cross-sectional study from NHANES 2017–2020 by Bo Yang, Mingsu Gong, Xiaojie Zhu, Yang Luo, Ruiqiu Li, Hai Meng, Yuhan Wang

Subjects: Get full text

From gut to liver: Exploring the crosstalk between gut-liver axis and oxidative stress in metabolic dysfunction-associated steatotic liver disease by Mi Zhou, Jianyu Lv, Xinli Chen, Yujie Shi, Guanqun Chao, Shuo Zhang

Subjects: Get full text

Helicobacter pylori Infection and Hepatobiliary Pathology by S. V. German, I. P. Bobrovnitsky

Subjects: Get full text

Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Geron... by V. T. Ivashkin, M. V. Maevskaya, M. S. Zharkova, Yu. V. Kotovskaya, O. N. Tkacheva, E. A. Troshina, M. V. Shestakova, I. V. Maev, V. V. Breder, N. I. Gheivandova, V. L. Doshchitsin, E. N. Dudinskaya, E. V. Ershova, Kh. B. Kodzoeva, K. A. Komshilova, N. V. Korochanskaya, A. Yu. Mayorov, E. E. Mishina, M. Yu. Nadinskaya, I. G. Nikitin, N. V. Pogosova, A. I. Tarzimanova, M. Sh. Shamkhalova

Subjects: Get full text

A randomized double-blind clinical trial investigating the effects of ellagic acid on glycemic status, liver enzymes, and oxidative stress in patients with non-alcoholic fatty live... by Sara Mighani, Rasoul Samimi, Mohamadreza Rashidi Nooshabadi, Seyed Amir Farzam, Hossein Khadem Haghighian, Maryam Javadi

Subjects: Get full text

The fibrosis-4 index and its association with carotid atherosclerosis in type 2 diabetes: a cross-sectional study in China by Ying Miao, Yu Wang, Qin Wan, Nanwei Tong

Subjects: Get full text

Clostridium Scindens Protects Against Vancomycin‐Induced Cholestasis and Liver Fibrosis by Activating Intestinal FXR‐FGF15/19 Signaling by Jintao Xiao, Yanliang Hou, Xingyang Luo, Yuhao Zhu, Wenhu Li, Bingbing Li, LinXiang Zhou, Xia Chen, Ying Guo, Xiaomei Zhang, Haiyue He, Xiaowei Liu

Subjects: “…cholestatic liver diseases…”
Get full text

Elevated Liver Function Tests as Predictors of Severe Maternal Outcomes in Women with Preeclampsia by Sadia Chaudhary, Hafiza Ateeqa Mubarak, Anila Sabir, Hina Sadaf, Anas Khalil, Zahid Mahmood, Marium Shoukat, Farah Naz Tahir

Subjects: Get full text

Effect of mRNA formulated with lipid nanoparticles on the transcriptomic and epigenetic profiles of F4/80+ liver-associated macrophages by Chitsuda Pongma, Pornlapat Keawvilai, Atsadang Boonmee, Benjawan Wongprom, Thitiporn Pattarakankul, Chutamath Sittplangkoon, Mohamad-Gabriel Alameh, Patipark Kueanjinda, James Heyes, Kieu Lam, Benjawan Saechue, Kiat Ruxrungtham, Tanapat Palaga

Subjects: Get full text

Commonly available dietary supplements, herbs and medicines – do they pose a risk for liver health? Literature review in the context of the Polish population by Ewa Janczewska, Barbara Janota

Subjects: “…liver…”
Get full text

Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease by Katarzyna Zdanowicz, Natalia Kopiczko, Marta Flisiak-Jackiewicz, Anna Bobrus-Chociej, Monika Kowalczuk-Kryston, Dariusz Lebensztejn

Subjects: Get full text

Review of Russian Abstracts Accepted for United European Gastroenterology Week (2022) by A. A. Sheptulin

Subjects: Get full text

Generalized tuberculosis with long-term course in the guise of liver cirrhosis by Z. A. Lemeshko, M. V. Mayevskaya, I. N. Tikhonov, N. P. Musina, M. S. Zharkova, Ye. V. Fominykh, V. T. Ivashkin

Subjects: Get full text